龍湖(00960.HK)合景(01813.HK)啟德「尚-珒(水盈)」為已打疫苗人士提供額外1%折扣
合景泰富(01813.HK) 及龍湖集團(00960.HK) 合作發展的啟德「尚-珒(水盈)」項目宣布,向已接種一劑或以上2019冠狀病毒病疫苗的買家,提供額外1%折扣優惠。
龍湖集團香港營銷總監黃少鴻表示,該項目自去年4月起一直提供為醫護人員售價1%的置業折扣,為了鼓勵香港市民接種疫苗,現將優惠擴展至已接種新冠疫苗的人士。
合景泰富海外拓展部香港區總經理蘇維文表示,期望透過今次優惠提升疫苗接種率,以保障社區健康。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.